Document is current
Any future updates will be listed below
-
Authors
Escudero-Sanchez, Rosa https://orcid.org/0000-0001-5736-8111
Ramos-Martínez, Antonio
Caballero-Bermejo, Antonio F.
Díaz-Pollán, Beatriz
Ruiz-Carrascoso, Guillermo
Samperio, María Olmedo
García, Patricia Muñoz
Amador, Paloma Merino
Romo, Fernando González
Segarra, Oriol Martín
Jiménez, Gema Navarro
del Campo Albendea, Laura
García, Alfonso Muriel
Cobo, Javier
- License Information
-
More Information
Article History
Received: 11 July 2023
Accepted: 12 January 2024
First Online: 18 January 2024
Declarations
:
: The study (Clinical Trials.gov identifier NCT04075422) was approved by the Clinical Research Ethics Committee from the coordinating centre.
: Informed consent was obtained from all individual participants included in the prospective cohort. Retrospective cohort was exempt from written informed consent.
: Not applicable.
: JC has received fees for lectures, advisory or congress attendance from MSD, Astellas, Tillotts, and Mikrobiomik. RE has received support from Gilead, Astellas, and MSD to attend conferences and congresses, as well as for speaking fees. All of the other authors had no conflicts to declare.
: The opinions expressed in this document responds to author’s opinions and not represent necessarily the Merck Sharp & Dohme Corp’s opinion.
